Victory Capital Management Inc. Sells 1,807 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Victory Capital Management Inc. trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.4% in the 4th quarter, Holdings Channel.com reports. The fund owned 455,217 shares of the medical equipment provider’s stock after selling 1,807 shares during the quarter. Victory Capital Management Inc.’s holdings in Intuitive Surgical were worth $237,605,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of ISRG. Massachusetts Financial Services Co. MA acquired a new stake in shares of Intuitive Surgical in the 3rd quarter worth $558,807,000. Proficio Capital Partners LLC raised its stake in Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after buying an additional 948,902 shares during the last quarter. FMR LLC raised its stake in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB boosted its holdings in Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after acquiring an additional 552,058 shares in the last quarter. Finally, Strategic Financial Concepts LLC grew its stake in shares of Intuitive Surgical by 50,740.8% during the fourth quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock worth $163,202,000 after acquiring an additional 312,056 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 12,598 shares of company stock worth $7,223,467. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of a number of recent analyst reports. Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Truist Financial boosted their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. Evercore ISI upped their target price on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Finally, Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Price Performance

ISRG opened at $557.96 on Wednesday. The firm has a fifty day moving average price of $571.08 and a 200 day moving average price of $530.63. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market cap of $198.73 billion, a P/E ratio of 87.05, a P/E/G ratio of 5.85 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.